MENCEVAX AC PWS INJ 2500MCG/VIAL
MENCEVAX AC PWS INJ 2500MCG/VIAL
Discontinued
DIN Number
01962930
Drug Class
Human
Market Date
Dec 31, 1992
Company
HC
GlaxoSmithKline Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number01962930
AIG Number0323419003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07AH03 MENINGOCOCCUS, A, C, BIVALENT PURIFIED POLYSACC. ANTIGEN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationSubcutaneous
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (3)
MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP AActive
Strength: 2.5 MG / VIAL
Monograph: MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A
MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP CActive
Strength: 2.5 MG / VIAL
Monograph: MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C
SODIUM CHLORIDEActive
Strength: 25 ML / VIAL
Monograph: SODIUM CHLORIDE